The Amyloidosis Channel

Explore the latest updates, including expert interviews, features, podcasts and e-learning

The Amyloidosis Channel on VJHemOnc is supported by Janssen Pharmaceuticals (a Johnson & Johnson Company). The supporters have no influence over the production of the content.

Welcome to The Amyloidosis Channel

Amyloidosis is the term given to a group of diseases in which the underlying pathogenesis is caused by the accumulation of amyloid, an abnormal, insoluble protein extracellularly.

Protein misfolding transforms soluble precursor proteins into insoluble amyloid fibrils. There are 4 main types of amyloidosis- AL (light chain), AA (inflammation), ATTR (hereditary and old age), and AB2M (caused by dialysis).

Amyloid fibrils can disseminate systemically and into organs, which eventually causes organ failure. Deposition in cardiac tissue, kidneys and central nervous system are the main causes of patient deterioration. Light chain amyloidosis, also known as AL amyloidosis due to clonal plasma cell dyscrasia is the most common type, with its incidence comparable to Hodgkin’s lymphoma or CML. This type usually affects the renal, cardiac, nervous and hepatic systems. It can occur alone or in conjunction with multiple myeloma, Waldenströms Macroglobulinemia or non-Hodgkin lymphoma.


EHA 2022
COMy 20222
Myeloma 2022
BSH 2022
ASH 2021
SOHO 2021


Disease Biology
Trial Updates
CAR-T therapy

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter